BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26405107)

  • 21. Insights into binding of cholera toxin to GM1 containing membrane.
    Basu I; Mukhopadhyay C
    Langmuir; 2014 Dec; 30(50):15244-52. PubMed ID: 25425333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second generation mimics of ganglioside GM1 as artificial receptors for cholera toxin: replacement of the sialic acid moiety.
    Bernardi A; Carrettoni L; Ciponte AG; Monti D; Sonnino S
    Bioorg Med Chem Lett; 2000 Oct; 10(19):2197-200. PubMed ID: 11012028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cooperativity of ganglioside-dependent with protein-dependent substratum adhesion and neurite extension of human neuroblastoma cells.
    Mugnai G; Culp LA
    Exp Cell Res; 1987 Apr; 169(2):328-44. PubMed ID: 3104072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 3-dependent mouse mast cells express the cholera toxin-binding acidic glycosphingolipid, ganglioside GM1, and increase their histamine content in response to toxin.
    Katz HR; Levine JS; Austen KF
    J Immunol; 1987 Sep; 139(5):1640-6. PubMed ID: 2957431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann-Pick C1-deficient cells.
    Sugimoto Y; Ninomiya H; Ohsaki Y; Higaki K; Davies JP; Ioannou YA; Ohno K
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12391-6. PubMed ID: 11675488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation.
    Francis ML; Ryan J; Jobling MG; Holmes RK; Moss J; Mond JJ
    J Immunol; 1992 Apr; 148(7):1999-2005. PubMed ID: 1312102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralization of cholera toxin with nanoparticle decoys for treatment of cholera.
    Das S; Angsantikul P; Le C; Bao D; Miyamoto Y; Gao W; Zhang L; Eckmann L
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006266. PubMed ID: 29470490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant fusion protein of cholera toxin B subunit with YVAD secreted by Lactobacillus casei inhibits lipopolysaccharide-induced caspase-1 activation and subsequent IL-1 beta secretion in Caco-2 cells.
    Hiramatsu Y; Yamamoto M; Satho T; Irie K; Kai A; Uyeda S; Fukumitsu Y; Toda A; Miyata T; Miake F; Arakawa T; Kashige N
    BMC Biotechnol; 2014 May; 14():38. PubMed ID: 24884459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding.
    Liljeqvist S; Ståhl S; Andréoni C; Binz H; Uhlén M; Murby M
    J Immunol Methods; 1997 Dec; 210(2):125-35. PubMed ID: 9520296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface immobilized cholera toxin B subunit (CTB) facilitates vesicle docking, trafficking and exocytosis.
    Soo JC; Zhang J; He Q; Agarwal S; Li H; Zhang H; Chen P
    Integr Biol (Camb); 2010 Jun; 2(5-6):250-7. PubMed ID: 20535419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GM1-Binding Conjugates To Improve Intestinal Permeability.
    Melkoumov A; St-Jean I; Banquy X; Leclair G; Leblond Chain J
    Mol Pharm; 2019 Jan; 16(1):60-70. PubMed ID: 30422668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.
    Van der Heijden PJ; Bianchi AT; Dol M; Pals JW; Stok W; Bokhout BA
    Immunology; 1991 Jan; 72(1):89-93. PubMed ID: 1705237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis.
    Ichikawa Y; Yamagata H; Tochikubo K; Udaka S
    FEMS Microbiol Lett; 1993 Aug; 111(2-3):219-24. PubMed ID: 8405930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes.
    Shi J; Yang T; Kataoka S; Zhang Y; Diaz AJ; Cremer PS
    J Am Chem Soc; 2007 May; 129(18):5954-61. PubMed ID: 17429973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescently labeled liposomes for monitoring cholera toxin binding to epithelial cells.
    Edwards KA; Duan F; Baeumner AJ; March JC
    Anal Biochem; 2008 Sep; 380(1):59-67. PubMed ID: 18549803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the binding of cholera toxin to ganglioside GM1 immobilized onto microtitre plates.
    Dawson RM
    J Appl Toxicol; 2005; 25(1):30-8. PubMed ID: 15669043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demonstration of GM1-ganglioside in nervous system in generalized GM1-gangliosidosis using cholera toxin B subunit.
    Iwamasa T; Ohshita T; Nashiro K; Iwanaga M
    Acta Neuropathol; 1987; 73(4):357-60. PubMed ID: 3113167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visualization of GM1 with cholera toxin B in live epididymal versus ejaculated bull, mouse, and human spermatozoa.
    Buttke DE; Nelson JL; Schlegel PN; Hunnicutt GR; Travis AJ
    Biol Reprod; 2006 May; 74(5):889-95. PubMed ID: 16452464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorescent derivatives of ganglioside GM1 function as receptors for cholera toxin.
    Spiegel S
    Biochemistry; 1985 Oct; 24(21):5947-52. PubMed ID: 3002428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of ganglioside GM1-binding peptides by using a phage library.
    Matsubara T; Ishikawa D; Taki T; Okahata Y; Sato T
    FEBS Lett; 1999 Aug; 456(2):253-6. PubMed ID: 10456319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.